{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:38:25Z","timestamp":1786984705250,"version":"build-2736575974"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.arbres.2021.05.033","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T15:40:56Z","timestamp":1644853256000},"page":"T159-T170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["[Translated article] Spanish COPD Guidelines (GesEPOC) 2021 Update. Diagnosis and Treatment of COPD Exacerbation Syndrome"],"prefix":"10.1016","volume":"58","author":[{"given":"Juan Jos\u00e9","family":"Soler-Catalu\u00f1a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascual","family":"Pi\u00f1era","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Antonio","family":"Trigueros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Calle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borja G.","family":"Cos\u00edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"L\u00f3pez-Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Almagro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-Tom\u00e1s","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Antonio","family":"Riesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Simonet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rigau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan B.","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Ancochea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Miravitlles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Supl 1","key":"10.1016\/j.arbres.2021.05.033_bib0005","first-page":"1","article-title":"Gu\u00eda de pr\u00e1ctica cl\u00ednica para el diagn\u00f3stico y tratamiento de pacientes con enfermedad pulmonar obstructiva cr\u00f3nica (EPOC) \u2022 Gu\u00eda Espa\u00f1ola de la EPOC (GesEPOC). Versi\u00f3n 2017","volume":"53","year":"2017","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2021.05.033_bib0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.arbres.2020.08.002","article-title":"GesEPOC 2021: One more step towards personalized treatment of COPD","volume":"57","author":"Miravitlles","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2021.05.033_bib0015","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.arbres.2019.02.020","article-title":"Patients with Chronic Obstructive Pulmonary Disease Exacerbations: Recommendations for Diagnosis, Treatment and Care","volume":"55","author":"Alc\u00e1zar Navarrete","year":"2019","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2021.05.033_bib0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.arbres.2021.03.005","article-title":"Spanish COPD guidelines (GesEPOC): Updated pharmacological treatment of stable COPD","volume":"58","author":"Miravitlles","year":"2022","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2021.05.033_bib0025","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.arbres.2020.07.008","article-title":"Exacerbation syndrome in COPD: A paradigm shift","volume":"57","author":"Soler-Catalu\u00f1a","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2021.05.033_bib0030","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.arbres.2012.12.001","article-title":"Calidad y fuerza: el sistema GRADE para la formulaci\u00f3n de recomendaciones en las gu\u00edas de pr\u00e1ctica cl\u00ednica","volume":"49","author":"Alonso-Coello","year":"2013","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2021.05.033_bib0035","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3109\/15412555.2010.496817","article-title":"Frequent chronic obstructive pulmonary disease exacerbators: how much real, how much fictitious?","volume":"4","author":"Soler-Catalu\u00f1a","year":"2010","journal-title":"COPD"},{"key":"10.1016\/j.arbres.2021.05.033_bib0040","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1183\/09031936.05.00136304","article-title":"Physiologic changes during symptom recovery from moderate exacerbation of COPD","volume":"26","author":"Parker","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2021.05.033_bib0045","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1183\/09031936.00092506","article-title":"Inflammatory changes, recovery and recurrence at COPD exacerbation","volume":"29","author":"Perera","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2021.05.033_bib0050","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/thx.54.7.581","article-title":"Usufulness of the Medical Research Council (MRC) dyspnea scale as a measure of disability in patients with chronic obstructive pulmonary disease","volume":"54","author":"Bestall","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2021.05.033_bib0055","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1164\/rccm.200603-380OC","article-title":"Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disaase. Diagnostic performance of cardiac biomarkers","volume":"174","author":"Abroug","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2021.05.033_bib0060","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00408-018-0137-3","article-title":"N-Terminal prohormone of brain natriuretic peptide (NT-proBNP) as a diagnostic biomarker of left ventricular systolic dysfunction in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD)","volume":"196","author":"Andrijevic","year":"2018","journal-title":"Lung"},{"key":"10.1016\/j.arbres.2021.05.033_bib0065","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/thx.2010.155333","article-title":"Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD","volume":"66","author":"Chang","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2021.05.033_bib0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134004","article-title":"The effect of incidental consolidation on managmenent and outcomes in COPD exacerbations: data from the European COPD Audit","volume":"10","author":"Saleh","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.arbres.2021.05.033_bib0075","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12931-018-0842-8","article-title":"Impact of radiologically stratified exacerbations: insights into pneumonia aetiology in COPD","volume":"19","author":"Williams","year":"2018","journal-title":"Respir Res"},{"key":"10.1016\/j.arbres.2021.05.033_bib0080","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4046\/trd.2018.0087","article-title":"Utility of computed tomography in a differential diagnosis for the patients with an initial diagnosis of chronic obstructive pulmonary disease exacerbation","volume":"82","author":"Park","year":"2019","journal-title":"Tuberc Respir Dis"},{"key":"10.1016\/j.arbres.2021.05.033_bib0085","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1378\/chest.13-0488","article-title":"Pneumonic and non-pneumonic exacerbations of COPD: inflammatory response and clinical characteristics","volume":"144","author":"Huerta","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2021.05.033_bib0090","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.arbres.2019.04.018","article-title":"Establishing the Prognosis of COPD Exacerbations Using Risk Scales from the Point of View of the Emergency Department","volume":"56","author":"Garc\u00eda Sanz","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2021.05.033_bib0095","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1378\/chest.10-3035","article-title":"Validation of a novel risk score for severity of illness in acute exacerbations of COPD","volume":"140","author":"Shorr","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2021.05.033_bib0100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/thoraxjnl-2011-200332","article-title":"Dyspnea severity and pneumonia as predictors of in-hospital mortality and early readmission in acute exacerbation of COPD","volume":"67","author":"Steer","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2021.05.033_bib0105","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/thoraxjnl-2012-202103","article-title":"The DECAF score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease","volume":"67","author":"Steer","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2021.05.033_bib0110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/thoraxjnl-2015-207775","article-title":"Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD","volume":"71","author":"Echevarria","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2021.05.033_bib0115","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-037923","article-title":"DECAF score as mortality predictor for acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"10","author":"Huang","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.arbres.2021.05.033_bib0120","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/thx.2005.041822","article-title":"COPD exacerbations: aetiology","volume":"61","author":"Sapey","year":"2006","journal-title":"Thorax."},{"key":"10.1016\/j.arbres.2021.05.033_bib0125","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1378\/chest.117.6.1638","article-title":"Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD","volume":"117","author":"Stockley","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2021.05.033_bib0130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/thx.2005.056374","article-title":"Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease","volume":"62","author":"Soler","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2021.05.033_bib0135","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ccm.2020.06.007","article-title":"Definition, causes, pathogenesis, and consequences of chronic obstructive pulmonary disease exacerbations","volume":"41","author":"Ritchie","year":"2020","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.arbres.2021.05.033_bib0140","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/jmv.23495","article-title":"Detection of multiple viral and bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a pilot prospective study","volume":"85","author":"Perotin","year":"2013","journal-title":"J Med Virol"},{"key":"10.1016\/j.arbres.2021.05.033_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta24150","article-title":"C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT","volume":"24","author":"Francis","year":"2020","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.arbres.2021.05.033_bib0150","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1803185","article-title":"C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations","volume":"381","author":"Butler","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2021.05.033_bib0155","article-title":"Procalcitonin-guided antibiotic therapy in acute exacerbation of chronic obstructive pulmonary disease: An updated meta-analysis","volume":"98","author":"Li","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.arbres.2021.05.033_bib0160","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/23744235.2019.1644456","article-title":"Potential of serum procalcitonin in predicting bacterial exacerbation and guiding antibiotic administration in severe COPD exacerbations: a systematic review and meta-analysis","volume":"51","author":"Ni","year":"2019","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.arbres.2021.05.033_bib0165","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Disease Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"Supl 1","key":"10.1016\/j.arbres.2021.05.033_bib0170","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.arbres.2020.01.015","article-title":"Neumon\u00eda intrahospitalaria. Normativa de la Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica (SEPAR). Actualizaci\u00f3n 2020","volume":"56","author":"Torres","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2021.05.033_bib0175","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1183\/13993003.01359-2015","article-title":"Treatable traits: toward precision medicine of chronic airway diseases","volume":"47","author":"Agusti","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2021.05.033_bib0180","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.2147\/COPD.S263430","article-title":"A Proposed Approach to Chronic Airway Disease (CAD) Using Therapeutic Goals and Treatable Traits: A Look to the Future","volume":"15","author":"P\u00e9rez de Llano","year":"2020","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"10.1016\/j.arbres.2021.05.033_bib0185","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.arbres.2013.07.008","article-title":"Consenso nacional sobre el diagn\u00f3stico, estratificaci\u00f3n de riesgo y tratamiento de los pacientes con tromboembolia pulmonar","volume":"49","author":"Uresandi","year":"2013","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2021.05.033_bib0190","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jemermed.2018.09.009","article-title":"Lung ultrasound for the emergency diagnosis of pneumonia, acute heart failure, and exacerbations of chronic obstructive pulmonar disease\/asthma in adults: a systematic review and meta-analysis","volume":"56","author":"J\u00f6nck","year":"2019","journal-title":"J Emerg Med"},{"key":"10.1016\/j.arbres.2021.05.033_bib0195","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.arbr.2019.02.013","article-title":"Thoracic Ultrasound: Present and Future","volume":"55","author":"Wang\u00f1\/4emert P\u00e9rez","year":"2019","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2021.05.033_bib0200","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.2147\/COPD.S214716","article-title":"Ultrasound assessment of diaphragmatic function during acute exacerbation of chronic obstructive pulmonary disease: a pilot study","volume":"14","author":"Lim","year":"2019","journal-title":"Int J Chron Obstr Pulm Dis"},{"key":"10.1016\/j.arbres.2021.05.033_bib0205","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1378\/chest.07-2800","article-title":"Relevance of lung ultrasound in the diagnosis of acute respiratory failure: The BLUE protocol","volume":"134","author":"Lichtenstein","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2021.05.033_bib0210","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.ajem.2019.02.028","article-title":"BLUE protocol ultrasonography in emergency department patients presenting with acute dyspnea","volume":"37","author":"Bekgoz","year":"2019","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.arbres.2021.05.033_bib0215","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"Hurst","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2021.05.033_bib0220","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1378\/chest.119.4.1190","article-title":"Management of acute exacerbations of COPD: a summary and appraisal of published evidence","volume":"119","author":"McCrory","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2021.05.033_bib0225","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/archinte.1997.00440360162018","article-title":"Bronchodilator delivery in acute airflow obstruction. A meta-analysis","volume":"157","author":"Turner","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.arbres.2021.05.033_bib0230","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.rmed.2006.03.007","article-title":"Effect of formoterol, tiotropium, and their combination in patients with acute exacerbations of chronic obstructive pulmonary disease: a pilot study","volume":"100","author":"Di Marco","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2021.05.033_bib0235","doi-asserted-by":"crossref","first-page":"1600791","DOI":"10.1183\/13993003.00791-2016","article-title":"Management of COPD exacerbations: A European Respiratory Society\/American Thoracic Society (ERS\/ATS) guideline","volume":"49","author":"Wedzicha","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2021.05.033_bib0240","article-title":"Antibiotics for exacerbations of chronic obstructive pulmonary disease (Review)","volume":"10","author":"Vollenweider","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arbres.2021.05.033_bib0245","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1164\/rccm.201206-0996OC","article-title":"Efficacy of antibiotic therapy for acute exacerbations of mild to moderate COPD","volume":"186","author":"Llor","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2021.05.033_bib0250","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/S0140-6736(01)07097-0","article-title":"Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial","volume":"358","author":"Nouira","year":"2001","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.arbres.2021.05.033_bib0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arbres.2020.01.014","article-title":"Community-Acquired Pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) guidelines. 2020 Update","volume":"56","author":"Men\u00e9ndez","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2021.05.033_bib0260","first-page":"461","article-title":"Manejo integral del paciente con exacerbaci\u00f3n de la EPOC","volume":"31","author":"Gonz\u00e1lez","year":"2018","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.arbres.2021.05.033_bib0265","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.arbres.2020.04.023","article-title":"Consensus document on the diagnosis and treatment of chronic bronchial infection in chronic obstructive pulmonary disease","volume":"56","author":"de la Rosa Carrillo","year":"2020","journal-title":"Arch Bronconeumol"},{"issue":"Issue 9","key":"10.1016\/j.arbres.2021.05.033_bib0270","first-page":"CD001288","article-title":"Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease","author":"Walters","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.arbres.2021.05.033_bib0275","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1164\/rccm.201108-1553OC","article-title":"Blood analysis to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease : a randomized placebo-controlled trial","volume":"186","author":"Bafadhel","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2021.05.033_bib0280","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S2213-2600(19)30176-6","article-title":"Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial","volume":"7","author":"Sivapalan","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.arbres.2021.05.033_bib0285","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1001\/jama.2013.5023","article-title":"Short-term vs Conventional Glucocorticoid Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary Disease. The REDUCE Randomized Clinical Trial","volume":"309","author":"Leuppi","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.arbres.2021.05.033_bib0290","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1157\/13116604","article-title":"Profilaxis de la enfermedad trombo\u00e9mb\u00f3lica venosa","volume":"44","author":"Otero","year":"2008","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2021.05.033_bib0295","first-page":"94","article-title":"Cardiovascular mortality and morbidity in chronic obstructive pulmonary disease: the impact of bronchodilator treatment","volume":"40","author":"Wood-Baker","year":"2010","journal-title":"Intern Med"},{"key":"10.1016\/j.arbres.2021.05.033_bib0300","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.pulmoe.2019.08.001","article-title":"High flow through nasal cannula in exacerbated COPD patients: a systematic review","volume":"25","author":"Pisani","year":"2019","journal-title":"Pulmonology"},{"key":"10.1016\/j.arbres.2021.05.033_bib0305","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/resp.13050","article-title":"Physiological effects of titrated oxygen via nasal high-flow cannulae in COPD exacerbations: a randomized controlled cross-over trial","volume":"22","author":"Pilcher","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.arbres.2021.05.033_bib0310","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.2147\/COPD.S185001","article-title":"Nasal high flow in acute hypercapnic exacerbation of COPD","volume":"13","author":"Br\u00e4unlich","year":"2018","journal-title":"Int J COPD"},{"key":"10.1016\/j.arbres.2021.05.033_bib0315","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1111\/crj.12772","article-title":"High flow nasal cannulae oxygen therapy in acute-moderate hypercapnic respiratory failure","volume":"12","author":"Lee","year":"2018","journal-title":"Clin Respir J"},{"key":"10.1016\/j.arbres.2021.05.033_bib0320","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2147\/COPD.S206567","article-title":"High flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease with acute-moderate hypercapnic respiratory failure: an observational cohort study","volume":"14","author":"Sun","year":"2019","journal-title":"Int J Chron Obstr Pulm Dis"},{"key":"10.1016\/j.arbres.2021.05.033_bib0325","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1186\/s13054-020-03409-0","article-title":"High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial","volume":"24","author":"Cortegiani","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.arbres.2021.05.033_bib0330","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/bmj.326.7382.185","article-title":"Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis","volume":"326","author":"Lightowler","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.arbres.2021.05.033_bib0335","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005305.pub3","article-title":"Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease","author":"Puhan","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arbres.2021.05.033_bib0340","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.2147\/COPD.S178149","article-title":"Validation of clinical control in COPD as a new tool for optimizing treatment","volume":"13","author":"Soler-Catalu\u00f1a","year":"2018","journal-title":"Int J Chron Obstr Pulm Dis"},{"key":"10.1016\/j.arbres.2021.05.033_bib0345","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.arbres.2019.06.004","article-title":"Clinical Control in COPD: A New Therapeutic Objective?","volume":"56","author":"Soler-Catalu\u00f1a","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2021.05.033_bib0350","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.arbres.2020.06.003","article-title":"Changes in control status of COPD over time and their Consequences: A prospective International Study","volume":"57","author":"Miravitlles","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2021.05.033_bib0355","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.chest.2019.11.004","article-title":"Evaluation of changes in control status in COPD: An opportunity for early intervention","volume":"157","author":"Soler-Catalu\u00f1a","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2021.05.033_bib0360","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.arbres.2021.01.025","article-title":"Implementation of an integrated care model for frequent-exacerbator COPD patients: a controlled prospective study","volume":"57","author":"Cosio","year":"2021","journal-title":"Arch Bronconeumol"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289622000175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289622000175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:41:23Z","timestamp":1759531283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289622000175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0300289622000175"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2021.05.033","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Translated article] Spanish COPD Guidelines (GesEPOC) 2021 Update. Diagnosis and Treatment of COPD Exacerbation Syndrome","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2021.05.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2021.05.011","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 SEPAR. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}